Calumet (CLMT) Stock Price, News & Analysis

Company Overview

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is a diversified downstream energy company specializing in the manufacture, marketing and distribution of refined hydrocarbon products. The company operates through two principal business segments: Specialty Products and Renewable Fuels. Calumet’s Specialty Products segment produces engineered products including solvents, waxes, lubricants, printing inks, pharmaceuticals and personal care ingredients. The Renewable Fuels segment encompasses the production and sale of biodiesel, renewable diesel and associated glycerin co‐products.

Calumet’s Specialty Products business caters to a wide range of end markets such as cosmetics, food and beverage, packaging, coatings, oilfield services and industrial cleaning. Its product portfolio features various types of white mineral oils, paraffin waxes, microcrystalline waxes and process oils, along with specialty solvents used in printing, adhesives and agricultural applications. The Renewable Fuels segment supports growing demand for lower carbon intensity fuels by operating biodiesel production facilities that convert vegetable oils and animal fats into marketable renewable diesel and feedstocks for green chemicals.

The company maintains a global manufacturing footprint with refining and processing plants located across North America and Europe. In the United States, Calumet operates refineries in Washington, Mississippi, Michigan and Pennsylvania. In Europe, the company serves customers from facilities in the Netherlands and Germany, and it benefits from an extensive logistics network for rail, barge, and truck transportation. Calumet’s distribution network extends to more than 50 countries, allowing it to support multinational customers and capitalize on international trade opportunities.

Founded in 2012 as a spin–off from Calumet Holdings, Calumet Specialty Products is headquartered in Indianapolis, Indiana. Under the leadership of John H. Pfeifer, President and Chief Executive Officer, and James A. Cox, Executive Vice President and Chief Financial Officer, the company has focused on strategic acquisitions, asset optimization and sustainable growth initiatives. Calumet’s management team leverages decades of downstream expertise to maintain operational reliability while pursuing opportunities in renewable and specialty hydrocarbon markets.

Key Stats

• Today's Range: $15.81 to $16.67
• 50-Day Range: $11.10 to $16.88
• 52-Week Range: $7.68 to $25.29
• Volume: 514,978 shs
• Average Volume: 1.05 million shs
• Market Capitalization: $1.43 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $18.50
• Consensus Rating: Moderate Buy

Calumet Stock Analysis - MarketRank™

Calumet scored higher than 22% of companies evaluated by MarketBeat, and ranked 235th out of 266 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Calumet has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Calumet has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Calumet are expected to grow in the coming year, from ($3.02) to $0.15 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Calumet is -4.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Calumet is -4.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

12.31% of the float of Calumet has been sold short.

Short Interest Ratio / Days to Cover

Calumet has a short interest ratio ("days to cover") of 7.5.

Change versus previous month

Short interest in Calumet has recently decreased by 0.35%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Calumet does not currently pay a dividend.

Dividend Growth

Calumet does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

12.31% of the float of Calumet has been sold short.

Short Interest Ratio / Days to Cover

Calumet has a short interest ratio ("days to cover") of 7.5.

Change versus previous month

Short interest in Calumet has recently decreased by 0.35%, indicating that investor sentiment is improving.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: 0.08

News Sentiment

Calumet has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Energy companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Calumet this week, compared to 4 articles on an average week.

Search Interest

Only 1 people have searched for CLMT on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Calumet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,147,258.00 in company stock.

Percentage Held by Insiders

Only 4.07% of the stock of Calumet is held by insiders.

Percentage Held by Institutions

Only 34.41% of the stock of Calumet is held by institutions.

CLMT Stock Analysis - Frequently Asked Questions

How have CLMT shares performed this year?

Calumet's stock was trading at $22.02 at the beginning of 2025. Since then, CLMT shares have decreased by 24.5% and is now trading at $16.63.

How were Calumet's earnings last quarter?

Calumet, Inc. (NASDAQ:CLMT) issued its quarterly earnings data on Friday, May, 9th. The oil and gas company reported ($1.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.41) by $0.62. The firm's revenue for the quarter was down 1.2% on a year-over-year basis.
Read the conference call transcript.

Does Calumet have any subsidiaries?

Calumet subsidiaries include these companies: Biosynthetic Technologies, Specialty Oil Field Solutions, Anchor Drilling Fluids USA, United Petroleum Company, Bel-Ray, Montana Renewables, Royal Purple, and more.

Who are Calumet's major shareholders?

Calumet's top institutional investors include Adams Asset Advisors LLC (6.27%). Insiders that own company stock include Jennifer Straumins, James S Carter, Stephen P Mawer, Scott Obermeier, Daniel J Sajkowski, Louis Todd Borgmann, Gregory J Morical, Ryan Willman and David Lunin.
View institutional ownership trends.

How do I buy shares of Calumet?

Shares of CLMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Calumet own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Calumet investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investments (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy (VNOM) and Summit Midstream Partners (SMLP).

Company Calendar

• Last Earnings: 5/09/2025
• Today: 7/10/2025
• Next Earnings (Estimated): 8/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Energy
• Industry: OIL - US INTEGRTD
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: NASDAQ:CLMT
• CIK: 1340122
• Web: www.calumetspecialty.com
• Phone: (317) 328-5660
• Fax: 317-328-2359
• Employees: 1,620
• Year Founded: 1916

Price Target and Rating

• Average Price Target for Calumet: $18.50
• High Price Target: $33.00
• Low Price Target: $12.00
• Potential Upside/Downside: +11.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($4.00)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$222 million
• Net Margins: -8.20%
• Pretax Margin: -8.17%
• Return on Equity: N/A
• Return on Assets: -8.77%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.06
• Quick Ratio: 0.61

Sales & Book Value

• Annual Sales: $4.19 billion
• Price / Sales: 0.34
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($8.28) per share
• Price / Book: -2.01

Miscellaneous

• Outstanding Shares: 86,210,000
• Free Float: 82,698,000
• Market Cap: $1.43 billion
• Optionable: Optionable
• Beta: 0.93